• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺激的强度决定了大麻素对 HIVgp120 的 T 细胞反应的差异。

Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.

机构信息

Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA.

出版信息

J Leukoc Biol. 2012 Nov;92(5):1093-102. doi: 10.1189/jlb.0212082. Epub 2012 Aug 16.

DOI:10.1189/jlb.0212082
PMID:22899554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3476243/
Abstract

Approximately 25% of immunocompromised HIV patients smoke marijuana for its putative therapeutic benefit. The goal of these studies was to test the hypothesis that marijuana-derived cannabinoids have immunomodulatory effects on HIV antigen-specific T cell effector function. A surrogate mouse model to induce polyclonal T cell responses against HIV(gp120) was established. THC, a marijuana-derived cannabinoid, suppressed or enhanced mouse CD8(+) T cell proliferation and the gp120-specific CTL response depending on the magnitude of the IFN-γ response. To determine the molecular mechanisms by which cannabinoids differentially modulate T cell responses, P/I or anti-CD3/CD28 antibodies were used for stimulation, and another marijuana-derived cannabinoid, CBD, was also investigated. THC or CBD suppressed or enhanced IFN-γ and IL-2 production by mouse splenocytes under optimal or suboptimal stimulation, respectively. Similar differential effects of cannabinoids on cytokine production were also observed on nuclear translocation of NFAT and with human PBMCs in response to P/I stimulation. However, THC and CBD elevated intracellular calcium, regardless of the stimulation level with P/I, suggesting that the cannabinoid-induced calcium increase provides an appropriate signal for activation in suboptimally stimulated T cells but an anergic-like signal as a result of excessive calcium in optimally stimulated T cells. Overall, these data demonstrate differential modulation by cannabinoids of a HIV antigen-specific response and identify a possible mechanism responsible for this effect.

摘要

大约 25%免疫功能低下的 HIV 患者吸烟大麻,因为它具有潜在的治疗益处。这些研究的目的是检验大麻衍生的大麻素对 HIV 抗原特异性 T 细胞效应功能是否具有免疫调节作用的假设。建立了一种用于诱导针对 HIV(gp120)的多克隆 T 细胞反应的替代小鼠模型。大麻衍生的大麻素 THC 取决于 IFN-γ 反应的幅度,抑制或增强了小鼠 CD8(+) T 细胞的增殖和 gp120 特异性 CTL 反应。为了确定大麻素差异调节 T 细胞反应的分子机制,使用 P/I 或抗-CD3/CD28 抗体进行刺激,并研究了另一种大麻衍生的大麻素 CBD。THC 或 CBD 分别在最佳或次优刺激下抑制或增强了小鼠脾细胞 IFN-γ 和 IL-2 的产生。在对 P/I 刺激的反应中,在核易位的 NFAT 和人类 PBMC 中也观察到了大麻素对细胞因子产生的类似差异效应。然而,无论用 P/I 进行刺激的水平如何,THC 和 CBD 都会增加细胞内钙,这表明大麻素诱导的钙增加为在次优刺激的 T 细胞中提供了适当的激活信号,但在最佳刺激的 T 细胞中由于钙过多而提供了一种类似无反应的信号。总的来说,这些数据表明大麻素对 HIV 抗原特异性反应具有差异调节作用,并确定了导致这种效应的可能机制。

相似文献

1
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.刺激的强度决定了大麻素对 HIVgp120 的 T 细胞反应的差异。
J Leukoc Biol. 2012 Nov;92(5):1093-102. doi: 10.1189/jlb.0212082. Epub 2012 Aug 16.
2
Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.体内大麻二酚(Δ9-四氢大麻酚)对 HIV-GP120 抗原特异性免疫应答的调节。
J Neuroimmune Pharmacol. 2015 Jun;10(2):344-55. doi: 10.1007/s11481-015-9597-x. Epub 2015 Apr 22.
3
Interferon--Mediated Activation of T Cells from Healthy and HIV-Infected Individuals Is Suppressed by Δ-Tetrahydrocannabinol.Δ-四氢大麻酚抑制健康个体和 HIV 感染者 T 细胞的干扰素介导的激活。
J Pharmacol Exp Ther. 2018 Oct;367(1):49-58. doi: 10.1124/jpet.118.250308. Epub 2018 Jul 19.
4
Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.围产期接触 Δ9-四氢大麻酚会在胎儿和出生后的生命阶段引发 T 细胞分化和功能的严重缺陷,包括对 HIV 抗原的反应性降低。
J Pharmacol Exp Ther. 2011 Nov;339(2):607-17. doi: 10.1124/jpet.111.181206. Epub 2011 Aug 10.
5
Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses.组蛋白修饰与Δ9-四氢大麻酚介导的抗原特异性T细胞反应改变有关。
J Biol Chem. 2014 Jul 4;289(27):18707-18. doi: 10.1074/jbc.M113.545210. Epub 2014 May 19.
6
The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).大麻二酚(CBD)的免疫调节概况涉及活化T细胞核因子(NFAT)的失调。
Biochem Pharmacol. 2008 Sep 15;76(6):726-37. doi: 10.1016/j.bcp.2008.06.022. Epub 2008 Jul 8.
7
Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.δ9-四氢大麻酚(∆9-THC)对激活的小鼠脾 CD4+T 细胞中 CD40 配体(CD40L)表达的差异调节。
J Neuroimmune Pharmacol. 2012 Dec;7(4):969-80. doi: 10.1007/s11481-012-9390-z. Epub 2012 Aug 1.
8
Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.Δ(9)-四氢大麻酚抑制人 CD4(+) T 细胞中 CD40 配体表达涉及 NFAT 和 NFκB 激活的抑制。
Toxicol Appl Pharmacol. 2013 Nov 15;273(1):209-18. doi: 10.1016/j.taap.2013.08.023. Epub 2013 Aug 30.
9
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.大麻素受体CB1和CB2靶向缺失对免疫能力及对Δ9-四氢大麻酚免疫调节敏感性的影响。
J Leukoc Biol. 2008 Dec;84(6):1574-84. doi: 10.1189/jlb.0508282. Epub 2008 Sep 12.
10
Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.在一项用于移植排斥反应的体外实验即混合淋巴细胞反应中,大麻素通过大麻素受体2抑制T细胞。
J Neuroimmune Pharmacol. 2013 Dec;8(5):1239-50. doi: 10.1007/s11481-013-9485-1. Epub 2013 Jul 4.

引用本文的文献

1
Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration.重度抑郁症中的免疫细胞耗竭与凋亡标志物:体外给予大麻二酚的影响
Brain Behav Immun Health. 2025 Jul 19;48:101066. doi: 10.1016/j.bbih.2025.101066. eCollection 2025 Oct.
2
Comparing the cannabidiol-induced transcriptomic profiles in human and mouse Sertoli cells.比较大麻二酚在人及小鼠睾丸支持细胞中诱导的转录组图谱。
Toxicology. 2025 Mar;512:154068. doi: 10.1016/j.tox.2025.154068. Epub 2025 Jan 31.
3
Cannabis use, oral dysbiosis, and neurological disorders.大麻使用、口腔生态失调与神经系统疾病。
NeuroImmune Pharm Ther. 2024 Aug 9;3(3-4):183-193. doi: 10.1515/nipt-2024-0012. eCollection 2024 Sep.
4
Antimicrobial, Probiotic, and Immunomodulatory Potential of Extract and Delivery Systems.提取物及递送系统的抗菌、益生菌及免疫调节潜力
Antibiotics (Basel). 2024 Apr 17;13(4):369. doi: 10.3390/antibiotics13040369.
5
Phytocannabinoids Reduce Inflammation of Primed Macrophages and Enteric Glial Cells: An In Vitro Study.植物大麻素可减轻预激活的巨噬细胞和肠神经胶质细胞的炎症:一项体外研究。
Int J Mol Sci. 2023 Sep 27;24(19):14628. doi: 10.3390/ijms241914628.
6
Impact of Cannabis Use on Immune Cell Populations and the Viral Reservoir in People With HIV on Suppressive Antiretroviral Therapy.抗逆转录病毒治疗抑制下的 HIV 感染者中,大麻使用对免疫细胞群体和病毒储存库的影响。
J Infect Dis. 2023 Nov 28;228(11):1600-1609. doi: 10.1093/infdis/jiad364.
7
In Vitro Effects of Cannabidiol on Activated Immune-Inflammatory Pathways in Major Depressive Patients and Healthy Controls.大麻二酚对重度抑郁症患者和健康对照者激活的免疫炎症途径的体外作用。
Pharmaceuticals (Basel). 2022 Mar 26;15(4):405. doi: 10.3390/ph15040405.
8
Cannabis and Autoimmunity: Possible Mechanisms of Action.大麻与自身免疫:可能的作用机制
Immunotargets Ther. 2021 Jul 21;10:261-271. doi: 10.2147/ITT.S267905. eCollection 2021.
9
Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain.大麻二酚可预防脂多糖诱导的病态行为,并改变大脑中的细胞因子和神经营养因子水平。
Pharmacol Rep. 2021 Dec;73(6):1680-1693. doi: 10.1007/s43440-021-00301-8. Epub 2021 Jul 3.
10
Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated Neurological Sequelae.混淆、病因还是治疗:大麻素对 HIV 相关神经后遗症的影响。
Viruses. 2021 Jun 26;13(7):1242. doi: 10.3390/v13071242.

本文引用的文献

1
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection.大麻素受体 1 和 2 的缺失会加剧 APC 功能,在流感感染期间增加炎症和细胞免疫。
J Leukoc Biol. 2011 Nov;90(5):983-95. doi: 10.1189/jlb.0511219. Epub 2011 Aug 26.
2
Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.Δ9-四氢大麻酚通过干扰早期激活事件,独立于 CB1 和 CB 2 抑制细胞毒性 T 淋巴细胞的功能。
J Neuroimmune Pharmacol. 2012 Dec;7(4):843-55. doi: 10.1007/s11481-011-9293-4. Epub 2011 Jul 26.
3
Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus.感染猴免疫缺陷病毒的恒河猴对慢性 delta-9-四氢大麻酚(Δ⁹-THC)的耐受性。
Exp Clin Psychopharmacol. 2011 Apr;19(2):154-72. doi: 10.1037/a0023000.
4
Cannabinoid administration attenuates the progression of simian immunodeficiency virus.给予大麻素可减缓猿猴免疫缺陷病毒的病程。
AIDS Res Hum Retroviruses. 2011 Jun;27(6):585-92. doi: 10.1089/aid.2010.0218. Epub 2010 Nov 23.
5
Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels.大麻二酚作用于线粒体以调节细胞内钙离子水平。
J Neurosci. 2009 Feb 18;29(7):2053-63. doi: 10.1523/JNEUROSCI.4212-08.2009.
6
Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.Delta9-四氢大麻酚对T细胞共刺激分子ICOS的抑制作用。
J Leukoc Biol. 2009 Feb;85(2):322-9. doi: 10.1189/jlb.0608390. Epub 2008 Nov 6.
7
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.大麻素受体CB1和CB2靶向缺失对免疫能力及对Δ9-四氢大麻酚免疫调节敏感性的影响。
J Leukoc Biol. 2008 Dec;84(6):1574-84. doi: 10.1189/jlb.0508282. Epub 2008 Sep 12.
8
Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells.半胱天冬酶3对信号蛋白的靶向切割抑制失能性T细胞中的T细胞受体信号传导。
Immunity. 2008 Aug 15;29(2):193-204. doi: 10.1016/j.immuni.2008.06.010.
9
The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).大麻二酚(CBD)的免疫调节概况涉及活化T细胞核因子(NFAT)的失调。
Biochem Pharmacol. 2008 Sep 15;76(6):726-37. doi: 10.1016/j.bcp.2008.06.022. Epub 2008 Jul 8.
10
Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120.抗原结构在人类对HIV包膜糖蛋白gp120的免疫反应中影响辅助性T细胞表位优势。
Eur J Immunol. 2008 May;38(5):1231-7. doi: 10.1002/eji.200738011.